Isoflavones in the management of menopause

Journal of the British Menopause Society

Volumn 7, Issue SUPPL. 1, 2001, Pages 8-12

  Nachtigall, L E ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHANIN A; DAIDZEIN; ESTRADIOL; ESTROGEN; FORMONONETIN; GENISTEIN; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN; RALOXIFENE; SEX HORMONE; SOYBEAN PROTEIN; TAMOXIFEN; UNCLASSIFIED DRUG;

ASIAN; BLEEDING; BONE DENSITY; BREAST CANCER; CANCER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE ASSOCIATION; FATALITY; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; MASTALGIA; MENOPAUSE; POPULATION RISK; POSTMENOPAUSE OSTEOPOROSIS; RED CLOVER; SIDE EFFECT; THROMBOEMBOLISM; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

EID: 0035077116     PISSN: 13621807     EISSN: None     Source Type: Journal    
DOI: 10.1258/136218001100321056     Document Type: Conference Paper

References (38)

1. Management of the menopause
2. Alternatives to estrogen for menopausal women
3. Estrogen replacement therapy indications contraindications, and agent selection
4. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey
5. Unconventional medicine in the United States. Prevalence, costs, and patterns of use
6. Phyto-oestrogens and Western diseases
7. The estrogenic and antiestrogenic activities of phytochemicals with human estrogen receptor expressed in yeast
8. Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor
9. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists
10. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ER alpha) and estrogen receptor-beta (ER beta) messenger ribonucleic acid in the wild-type and ER alpha-knockout mouse
11. The distribution of oestrogenic isoflavones in the genus Trifolium
12. Dietary phyto-oestrogens and the menopause in Japan
13. Menopausal experiences of Thai women. Part 1: Symptoms and their correlates
14. Menopausal experiences of Thai women. Part 2: The cultural context
15. A randomised placebo controlled trial of an isoflavone supplement and menopausal symptoms in women
16. The effect of isoflavone phytoestrogens in relieving hot flushes in Peruvian post-menopausal women
17. The effect of isoflavones derived from red clover on vasomotor symptoms and endometrical thickness
18. Effect of chronic treatment with ipriflavone in postmenopausal women with lowbone mass
19. Ipriflavone has no effect on bone metabolism and causes lymphopaenia in osteoporotic women
20. The effects of isoflavone phytoestrogens on bone; preliminary results from a large randomised controlled study
21. The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism
22. Effects of dietary phytoestrogens in postmenopausal women
23. Clinical review 97: Potential health benefits of dietary phytoestrogens: A review of the clinical, epidemiological, and mechanistic evidence
24. Case-control study of phyto-oestrogens and breast cancer
25. Phyto-oestrogens and breast cancer
26. Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women
27. Genistein, a specific inhibitor of tyrosine-specific protein kinases
28. Flavonoids as DNA topoisomerase antagonists and poisons: Structure-activity relationships
29. Genistein arrests cell cycle progression at G2-M
30. Genistein as an inducer of tumor cell differentiation: Possible mechanisms of action
31. Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids
32. Flavonoid inhibition of aromatase enzyme activity in human preadipocytes
33. Antioxidant activities of isoflavones and their biological metabolites in a liposomal system
34. Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases
35. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis
36. Genistein-stimulated adherence of prostate cancer cells is associated with the binding of focal adhesion kinase to beta-1-integrin